A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
Status:
Completed
Trial end date:
2018-06-12
Target enrollment:
Participant gender:
Summary
This is a single center single arm study of 50 patients to 1) determine the safety of
tranexamic acid in the chronic subdural hematoma population following surgical drainage of
chronic subdural hematomas and 2) determine if the use of oral tranexamic acid reduces the
rate of ipsilateral recurrence following drainage of chronic subdural hematomas. This will be
compared to historical controls. This study intends to be a prerequisite to a large
nationally funded randomized control trial.